TransUnion Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by TransUnion on June 6, 2016, with a signature date of June 10, 2016. The filing reports the entry into a Material Definitive Agreement regarding an underwritten offering of common stock and the subsequent exercise of an underwriters' option.
Key Financial Metrics
The filing does not provide standard financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a secondary offering of shares by a Selling Stockholder. Key transaction metrics include:
- Initial Offering: 15,652,500 shares of Common Stock.
- Offering Price: $32.10 per share.
- Option Exercise: Underwriters exercised their option to purchase an additional 2,347,500 shares.
- Total Shares Sold: 18,000,000 shares.
- Settlement Date: June 10, 2016.
- Proceeds: All net proceeds were received by the Selling Stockholder; the Company received no proceeds from this offering.
Material Changes
The primary material change is the increase in the number of outstanding shares of TransUnion Common Stock due to the sale of 18,000,000 shares by a Selling Stockholder. This transaction does not represent a change in the Company's operational performance or balance sheet liabilities, as no new capital was raised by the Company.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook for future periods. It does not disclose specific risks or contingencies beyond the standard terms of the Underwriting Agreement. The transaction was conducted pursuant to a Registration Statement on Form S-3.
Investor Verification Checklist
- Verify the identity of the "Selling Stockholder" to understand the source of the shares sold.
- Confirm the total number of outstanding shares post-transaction to assess potential dilution.
- Review the Underwriting Agreement (Exhibit 1.1) for lock-up provisions or other restrictions on the Selling Stockholder.
- Note that the Company received zero proceeds from this transaction; verify if this aligns with the Company's capital strategy.